No abstract available
Keywords:
SGLT2i; United States; chronic kidney disease; diabetes mellitus; proteinuria; sodium-glucose transporter 2; sodium-glucose transporter 2 inhibitors; type 2.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Clinical Trials as Topic
-
Delivery of Health Care, Integrated / legislation & jurisprudence
-
Delivery of Health Care, Integrated / organization & administration*
-
Evidence-Based Medicine
-
Glomerular Filtration Rate / drug effects*
-
Government Regulation
-
Health Policy
-
Humans
-
Kidney / drug effects*
-
Kidney / physiopathology
-
Renal Insufficiency, Chronic / diagnosis
-
Renal Insufficiency, Chronic / drug therapy*
-
Renal Insufficiency, Chronic / epidemiology
-
Renal Insufficiency, Chronic / physiopathology
-
Sodium-Glucose Transporter 2 Inhibitors / adverse effects
-
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
-
Treatment Outcome
-
United States / epidemiology
Substances
-
Sodium-Glucose Transporter 2 Inhibitors